NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
Endocrinology Advisor22h
January 2025 Recap: Drug Pipeline Updates
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
GB News on MSN11h
High blood pressure: Diet shown to wean patients off hypertension drugs within months in landmark study
A ketogenic diet has proven significantly more effective at reducing blood pressure in women with hypertension compared to ...
El Mundo on MSN14h
US approves a new painkiller with less risk of addiction than opioids and equally potent
The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
BMJ11h
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Conclusion The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion. Since 2008, when the first EULAR recommendations for the management ...